rs334348

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004612.4(TGFBR1):​c.*884A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.291 in 189,906 control chromosomes in the GnomAD database, including 8,573 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6428 hom., cov: 32)
Exomes 𝑓: 0.31 ( 2145 hom. )

Consequence

TGFBR1
NM_004612.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.601

Publications

57 publications found
Variant links:
Genes affected
TGFBR1 (HGNC:11772): (transforming growth factor beta receptor 1) The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TGFBR1 Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Loeys-Dietz syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Loeys-Dietz syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P
  • multiple self-healing squamous epithelioma
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 9-99150189-A-G is Benign according to our data. Variant chr9-99150189-A-G is described in ClinVar as Benign. ClinVar VariationId is 364112.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.454 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGFBR1NM_004612.4 linkc.*884A>G 3_prime_UTR_variant Exon 9 of 9 ENST00000374994.9 NP_004603.1 P36897-1Q5T7S2B4DXN7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFBR1ENST00000374994.9 linkc.*884A>G 3_prime_UTR_variant Exon 9 of 9 1 NM_004612.4 ENSP00000364133.4 P36897-1

Frequencies

GnomAD3 genomes
AF:
0.285
AC:
43342
AN:
152004
Hom.:
6408
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.315
Gnomad AMI
AF:
0.198
Gnomad AMR
AF:
0.285
Gnomad ASJ
AF:
0.244
Gnomad EAS
AF:
0.469
Gnomad SAS
AF:
0.323
Gnomad FIN
AF:
0.212
Gnomad MID
AF:
0.225
Gnomad NFE
AF:
0.266
Gnomad OTH
AF:
0.278
GnomAD4 exome
AF:
0.315
AC:
11884
AN:
37782
Hom.:
2145
Cov.:
0
AF XY:
0.315
AC XY:
5518
AN XY:
17542
show subpopulations
African (AFR)
AF:
0.305
AC:
454
AN:
1490
American (AMR)
AF:
0.258
AC:
244
AN:
944
Ashkenazi Jewish (ASJ)
AF:
0.233
AC:
563
AN:
2414
East Asian (EAS)
AF:
0.546
AC:
3641
AN:
6672
South Asian (SAS)
AF:
0.373
AC:
123
AN:
330
European-Finnish (FIN)
AF:
0.266
AC:
102
AN:
384
Middle Eastern (MID)
AF:
0.212
AC:
45
AN:
212
European-Non Finnish (NFE)
AF:
0.262
AC:
5851
AN:
22310
Other (OTH)
AF:
0.285
AC:
861
AN:
3026
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
373
747
1120
1494
1867
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.285
AC:
43415
AN:
152124
Hom.:
6428
Cov.:
32
AF XY:
0.283
AC XY:
21086
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.316
AC:
13105
AN:
41484
American (AMR)
AF:
0.284
AC:
4344
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.244
AC:
844
AN:
3466
East Asian (EAS)
AF:
0.469
AC:
2428
AN:
5176
South Asian (SAS)
AF:
0.323
AC:
1562
AN:
4830
European-Finnish (FIN)
AF:
0.212
AC:
2247
AN:
10602
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.265
AC:
18046
AN:
67972
Other (OTH)
AF:
0.281
AC:
594
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1605
3210
4816
6421
8026
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.259
Hom.:
8123
Bravo
AF:
0.289
Asia WGS
AF:
0.398
AC:
1381
AN:
3468

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial thoracic aortic aneurysm and aortic dissection Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Loeys-Dietz syndrome 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Loeys-Dietz syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome Benign:1
Nov 15, 2019
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
8.2
DANN
Benign
0.87
PhyloP100
0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs334348; hg19: chr9-101912471; API